AbbVie Inc.
Date updated: 2026-04-19
TOTAL PRODUCT APPROVED: 2
Overview
Product Registered
Categories
Type of Products
Analysis
Product Holder
| Product holder name | Product count |
|---|---|
| 2 |
Product count2
Rows per page:
1–1 of 1
Analysis
Product API
| Ingredient (API) name | Product count |
|---|---|
| 2 |
Product count2
Rows per page:
1–1 of 1
Listing
Registered Product
| Product name | Product Reg. no | Type | Product Holder | Manufacturer | Importer | Registration Status |
|---|---|---|---|---|---|---|
| SURVANTA 4ML | MAL20020869AZ | NEW CHEMICAL ENTITY | ABBVIE SDN BHD | AbbVie Inc. | ABBVIE SDN BHD | PRODUCT APPROVED |
| SURVANTA INTRATRACHEAL SUSPENSION | MAL19930547ARZ | NEW CHEMICAL ENTITY | ABBVIE SDN BHD | AbbVie Inc. | ABBVIE SDN BHD | PRODUCT APPROVED |
SURVANTA 4ML
Product Reg. noMAL20020869AZ
TypeNEW CHEMICAL ENTITY
Product HolderABBVIE SDN BHD
ManufacturerAbbVie Inc.
ImporterABBVIE SDN BHD
Registration StatusPRODUCT APPROVED
SURVANTA INTRATRACHEAL SUSPENSION
Product Reg. noMAL19930547ARZ
TypeNEW CHEMICAL ENTITY
Product HolderABBVIE SDN BHD
ManufacturerAbbVie Inc.
ImporterABBVIE SDN BHD
Registration StatusPRODUCT APPROVED
Rows per page:
1–2 of 2